Trial Profile
Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy- a Double-Blind Placebo-Controlled Study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Drug dependence
- Focus Therapeutic Use
- 28 Feb 2017 New trial record